SEC Tracker
Get the app

Halozyme Therapeutics HALO

Halozyme Therapeutics Bernadette Connaughton corrected RSU grant from 6,796 to 3,796

Bernadette Connaughton, insider filing for HALO (amended)

Form
4/A
Filed
Importance
Routine
  1. Corrected RSU grant from 6,796 to 3,796
  2. RSUs vest on May 5, 2027 or next annual meeting

Written from the Form 4/A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.